Brought to you by
ECR 2015 / C-0222
Diagnostic value of MRI proton density fat fraction for assessing liver steatosis in chronic viral C hepatitis
This poster is published under an open license. Please read the disclaimer for further details.
Congress: ECR 2015
Poster No.: C-0222
Type: Scientific Exhibit
Keywords: Tissue characterisation, Metabolic disorders, Infection, Technical aspects, Diagnostic procedure, Computer Applications-General, Ultrasound, MR, MR physics, Liver, Abdomen
Authors: R. Piccazzo1, F. Paparo1, L. Bacigalupo1, M. Revelli1, L. Cevasco1, L.-P. Rollandi1, A. Galletto2, G. A. Rollandi1; 1Genoa/IT, 2Borgio Verezzi/IT
DOI:10.1594/ecr2015/C-0222

References

1: Negro F. Mechanisms and significance of liver steatosis in hepatitis C virus infection. World J Gastroenterol. 2006 Nov 14;12(42):6756-65. Review. PubMed PMID: 17106922.
2: Asselah T, Rubbia-Brandt L, Marcellin P, Negro F. Steatosis in chronic hepatitis C: why does it really matter? Gut. 2006 Jan;55(1):123-30. Review. PubMed PMID: 16344578; PubMed Central PMCID: PMC1856395.
3: Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology. 2001 Jun;33(6):1358-64. PubMed PMID: 11391523.
4: Fernández-Salazar L, Velayos B, Aller R, Lozano F, Garrote JA, González JM. Percutaneous liver biopsy: patients' point of view. Scand J Gastroenterol. 2011 Jun;46(6):727-31. doi:10.3109/00365521.2011.558112. Epub 2011 Mar 2. PubMed PMID: 21366386.
5: Qayyum A, Chen DM, Breiman RS, Westphalen AC, Yeh BM, Jones KD, Lu Y, Coakley FV, Callen PW. Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best? Clin Imaging. 2009 Mar-Apr;33(2):110-5. doi: 10.1016/j.clinimag.2008.06.036. PubMed PMID: 19237053; PubMed Central PMCID: PMC2743961.
6: Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy. J Magn Reson Imaging. 2011 Oct;34(4):spcone. PubMed PMID: 22025886; PubMed Central PMCID: PMC3177109.
7: Wu CH, Ho MC, Jeng YM, Hsu CY, Liang PC, Hu RH, Lai HS, Shih TT. Quantification of hepatic steatosis: a comparison of the accuracy among multiple magnetic resonance techniques. J Gastroenterol Hepatol. 2014 Apr;29(4):807-13. doi: 10.1111/jgh.12451. PubMed PMID: 24224538.
8: Kang BK, Yu ES, Lee SS, Lee Y, Kim N, Sirlin CB, Cho EY, Yeom SK, Byun JH, Park SH, Lee MG. Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard. Invest Radiol. 2012 Jun;47(6):368-75. doi: 10.1097/RLI.0b013e31824baff3. PubMed PMID: 22543969.
9: Bohte AE, van Werven JR, Bipat S, Stoker J. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol. 2011 Jan;21(1):87-97. doi: 10.1007/s00330-010-1905-5. Epub 2010 Jul 31. PubMed PMID: 20680289; PubMed Central PMCID: PMC2995875.
10: Tang A, Tan J, Sun M, Hamilton G, Bydder M, Wolfson T, Gamst AC, Middleton M, Brunt EM, Loomba R, Lavine JE, Schwimmer JB, Sirlin CB. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology. 2013 May;267(2):422-31. doi: 10.1148/radiol.12120896. Epub 2013 Feb 4. PubMed PMID: 23382291; PubMed Central PMCID: PMC3632805.
11: Yokoo T, Bydder M, Hamilton G, Middleton MS, Gamst AC, Wolfson T, Hassanein T, Patton HM, Lavine JE, Schwimmer JB, Sirlin CB. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology. 2009 Apr;251(1):67-76. doi:10.1148/radiol.2511080666. Epub 2009 Feb 12. PubMed PMID: 19221054; PubMed Central PMCID: PMC2663579.
12: Meisamy S, Hines CD, Hamilton G, Sirlin CB, McKenzie CA, Yu H, Brittain JH, Reeder SB. Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology. 2011 Mar;258(3):767-75. doi: 10.1148/radiol.10100708. Epub 2011 Jan 19. PubMed PMID: 21248233; PubMed Central PMCID: PMC3042638.
13: Guiu B, Petit JM, Loffroy R, Ben Salem D, Aho S, Masson D, Hillon P, Krause D, Cercueil JP. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy. Radiology. 2009 Jan;250(1):95-102. doi:10.1148/radiol.2493080217. PubMed PMID: 19092092.
14: Mehta SR, Thomas EL, Bell JD, Johnston DG, Taylor-Robinson SD. Non-invasive means of measuring hepatic fat content. World J Gastroenterol. 2008 Jun 14;14(22):3476-83. PubMed PMID: 18567074; PubMed Central PMCID: PMC2716608.
15: Awai HI, Newton KP, Sirlin CB, Behling C, Schwimmer JB. Evidence and recommendations for imaging liver fat in children, based on systematic review. Clin Gastroenterol Hepatol. 2014 May;12(5):765-73. doi:10.1016/j.cgh.2013.09.050. Epub 2013 Sep 30. PubMed PMID: 24090729; PubMed Central PMCID: PMC3969892.
16: Lee SS, Park SH, Kim HJ, Kim SY, Kim MY, Kim DY, Suh DJ, Kim KM, Bae MH, Lee JY, Lee SG, Yu ES. Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol. 2010 Apr;52(4):579-85. doi:10.1016/j.jhep.2010.01.008. Epub 2010 Feb 2. PubMed PMID:20185194.
17: Fischer MA, Nanz D, Reiner CS, Montani M, Breitenstein S, Leschka S, Alkadhi H, Stolzmann P, Marincek B, Scheffel H. Diagnostic performance and accuracy of 3-D spoiled gradient-dual-echo MRI with water- and fat-signal separation in liver-fat quantification: comparison to liver biopsy. Invest Radiol. 2010 Aug;45(8):465-70. doi: 10.1097/RLI.0b013e3181da1343. PubMed PMID: 20479652.
18: Kühn JP, Evert M, Friedrich N, Kannengiesser S, Mayerle J, Thiel R, Lerch MM, Dombrowski F, Mensel B, Hosten N, Puls R. Noninvasive quantification of hepatic fat content using three-echo dixon magnetic resonance imaging with correction for T2* relaxation effects. Invest Radiol. 2011 Dec;46(12):783-9. doi:10.1097/RLI.0b013e31822b124c. PubMed PMID: 21808200.
19: Henninger B, Kremser C, Rauch S, Eder R, Judmaier W, Zoller H, Michaely H, Schocke M. Evaluation of liver fat in the presence of iron with MRI using T2* correction: a clinical approach. Eur Radiol. 2013 Jun;23(6):1643-9. doi:10.1007/s00330-012-2745-2. Epub 2013 Jan 19.
20: Bydder M, Yokoo T, Hamilton G, Middleton MS, Chavez AD, Schwimmer JB, Lavine JE, Sirlin CB. Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging. 2008 Apr;26(3):347-59. Epub 2008 Feb 21. PubMed PMID: 18093781; PubMed Central PMCID: PMC2386876.
21: Yu H, McKenzie CA, Shimakawa A, Vu AT, Brau AC, Beatty PJ, Pineda AR, Brittain JH, Reeder SB. Multiecho reconstruction for simultaneous water-fat decomposition and T2* estimation. J Magn Reson Imaging. 2007 Oct;26(4):1153-61. PubMed PMID:17896369.
22: Idilman IS, Aniktar H, Idilman R, Kabacam G, Savas B, Elhan A, Celik A, Bahar K, Karcaaltincaba M. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology. 2013 Jun;267(3):767-75. doi:10.1148/radiol.13121360. Epub 2013 Feb 4. PubMed PMID: 23382293.
23: Yu H, Shimakawa A, McKenzie CA, Brodsky E, Brittain JH, Reeder SB. Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn Reson Med. 2008 Nov;60(5):1122-34. doi:10.1002/mrm.21737. PubMed PMID: 18956464; PubMed Central PMCID: PMC3070175.
24: Idilman IS, Keskin O, Elhan AH, Idilman R, Karcaaltincaba M. Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease. Scand J Gastroenterol. 2014 May;49(5):617-24. doi: 10.3109/00365521.2014.894118. Epub 2014 Apr 2. PubMed PMID: 24694249.
25: Ghotb A, Noworolski SM, Madden E, Scherzer R, Qayyum A, Pannell J, Ferrell L, Peters M, Tien PC. Adipose tissue and metabolic factors associated with steatosis in HIV/HCV coinfection: histology versus magnetic resonance spectroscopy. J Acquir Immune Defic Syndr. 2010 Oct;55(2):228-31. doi: 10.1097/QAI.0b013e3181e1d963. PubMed PMID: 20512045; PubMed Central PMCID: PMC2943991.
26: Mitchell DG, Navarro VJ, Herrine SK, Bergin D, Parker L, Frangos A, McCue P, Rubin R. Compensated hepatitis C: unenhanced MR imaging correlated with pathologic grading and staging. Abdom Imaging. 2008 Jan-Feb;33(1):58-64. PubMed PMID: 17387539.
27: Orlacchio A, Bolacchi F, Cadioli M, Bergamini A, Cozzolino V, Angelico M, Simonetti G. Evaluation of the severity of chronic hepatitis C with 3-T1H-MR spectroscopy. AJR Am J Roentgenol. 2008 May;190(5):1331-9. doi: 10.2214/AJR.07.2262. PubMed PMID: 18430852.
28: Dewey M, Schink T, Dewey CF. Frequency of referral of patients with safety-related contraindications to magnetic resonance imaging. Eur J Radiol. 2007 Jul;63(1):124-7. Epub 2007 Mar 23. PubMed PMID: 17383136.
29: Thampanitchawong P, Piratvisuth T. Liver biopsy:complications and risk factors. World J Gastroenterol. 1999 Aug;5(4):301-304. PubMed PMID: 11819452.

30: Angelucci E, Giovagnoni A, Valeri G, Paci E, Ripalti M, Muretto P, McLaren C, Brittenham GM, Lucarelli G. Limitations of magnetic resonance imaging in measurement of hepatic iron. Blood. 1997 Dec 15;90(12):4736-42. PubMed PMID:9389689.
31: Paparo F, Cevasco L, Zefiro D, Biscaldi E, Bacigalupo L, Balocco M, Pongiglione M, Banderali S, Forni GL, Rollandi GA. Diagnostic value of real-time elastography in the assessment of hepatic fibrosis in patients with liver iron overload. Eur J Radiol. 2013 Dec;82(12):e755-61. doi:10.1016/j.ejrad.2013.08.038. Epub 2013 Aug 30. PubMed PMID: 24050879.
32: Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, Christidis C, Ziol M, Poulet B, Kazemi F, Beaugrand M, Palau R. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003 Dec;29(12):1705-13. PubMed PMID: 14698338.
33: Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, de Lédinghen V, Marcellin P, Dhumeaux D, Trinchet JC, Beaugrand M. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005 Jan;41(1):48-54. PubMed PMID: 15690481.
34: Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996 Aug;24(2):289-93. PubMed PMID: 8690394.
35: Theise ND. Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach. Mod Pathol. 2007 Feb;20 Suppl 1:S3-14. Review. PubMed PMID:17486049.
36: Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ; Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005 Jun;41(6):1313-21. PubMed PMID: 15915461.
37: Bülow R, Mensel B, Meffert P, Hernando D, Evert M, Kühn JP. Diffusion-weighted magnetic resonance imaging for staging liver fibrosis is less reliable in the presence of fat and iron. Eur Radiol. 2013 May;23(5):1281-7. doi:10.1007/s00330-012-2700-2. Epub 2012 Nov 9. PubMed PMID: 23138385.
38: Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003 Dec;38(6):1449-57. PubMed PMID: 14647056.
39: Marshall RH, Eissa M, Bluth EI, Gulotta PM, Davis NK. Hepatorenal index as an accurate, simple, and effective tool in screening for steatosis. AJR Am J Roentgenol. 2012 Nov;199(5):997-1002. doi: 10.2214/AJR.11.6677. PubMed PMID:23096171.
40: Rubbia-Brandt L, Quadri R, Abid K, Giostra E, Malé PJ, Mentha G, Spahr L, Zarski JP, Borisch B, Hadengue A, Negro F. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol. 2000 Jul;33(1):106-15. PubMed PMID: 10905593.

41: Kumar D, Farrell GC, Fung C, George J. Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response. Hepatology. 2002 Nov;36(5):1266-72. PubMed PMID: 12395339.
42: Rubbia-Brandt L, Fabris P, Paganin S, Leandro G, Male PJ, Giostra E, Carlotto A, Bozzola L, Smedile A, Negro F. Steatosis affects chronic hepatitis C progression in a genotype specific way. Gut. 2004 Mar;53(3):406-12. PubMed PMID:14960525; PubMed Central PMCID: PMC1773989.
43: Abdelmalek M, Ludwig J, Lindor KD. Two cases from the spectrum of nonalcoholic steatohepatitis. J Clin Gastroenterol. 1995 Mar;20(2):127-30. PubMed PMID:7769192.
44: Fartoux L, Chazouillères O, Wendum D, Poupon R, Serfaty L. Impact of steatosis on progression of fibrosis in patients with mild hepatitis C. Hepatology. 2005 Jan;41(1):82-7. PubMed PMID: 15690484.
45: Pirisi M, Scott CA, Avellini C, Toniutto P, Fabris C, Soardo G, Beltrami CA, Bartoli E. Iron deposition and progression of disease in chronic hepatitis C. Role of interface hepatitis, portal inflammation, and HFE missense mutations. Am J Clin Pathol. 2000 Apr;113(4):546-54. PubMed PMID: 10761457.

POSTER ACTIONS Add bookmark Contact presenter Send to a friend Download pdf
SHARE THIS POSTER
2 clicks for more privacy: On the first click the button will be activated and you can then share the poster with a second click.

This website uses cookies. Learn more